Cargando…
Serum IgA, IgM, and IgG responses in COVID-19
Autores principales: | Ma, Huan, Zeng, Weihong, He, Hongliang, Zhao, Dan, Jiang, Dehua, Zhou, Peigen, Cheng, Linzhao, Li, Yajuan, Ma, Xiaoling, Jin, Tengchuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331804/ https://www.ncbi.nlm.nih.gov/pubmed/32467617 http://dx.doi.org/10.1038/s41423-020-0474-z |
Ejemplares similares
-
Decline of SARS-CoV-2-specific IgG, IgM and IgA in convalescent COVID-19 patients within 100 days after hospital discharge
por: Ma, Huan, et al.
Publicado: (2020) -
Landscape of the RBD-specific IgG, IgM, and IgA responses triggered by the inactivated virus vaccine against the Omicron variant
por: Xue, Jun-biao, et al.
Publicado: (2022) -
Reference ranges for serum immunoglobulin (IgG, IgA, and IgM) and IgG subclass levels in healthy children
por: BAYRAM, Rumeysa Olcay, et al.
Publicado: (2019) -
Competition between Serum IgG, IgM, and IgA Anti-Glycan Antibodies
por: Muthana, Saddam M., et al.
Publicado: (2015) -
Detection of serum IgM and IgG for COVID-19 diagnosis
por: Zhong, Ling, et al.
Publicado: (2020)